Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-036402
Filing Date
2021-09-17
Accepted
2021-09-17 14:25:07
Documents
2
Period of Report
2021-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11525
2 EX-99.1 DOCUMENT attachment1.htm EX-99.1 861
  Complete submission text file 0000899243-21-036402.txt   14993
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Reporting) CIK: 0001601086 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 211259974

Mailing Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address C/O ARMISTICE CAPITAL, LLC 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 212-231-4932
Armistice Capital Master Fund Ltd. (Reporting) CIK: 0001633584 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 211259973

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address
Boyd Steven (Reporting) CIK: 0001706140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 211259972